Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name JNJ-78278343
Trade Name
Synonyms JNJ78278343|JNJ 78278343
Drug Descriptions

JNJ-78278343 is a humanized IgG1 bispecific antibody that targets KLK2 on tumor cells and CD3 on T lymphocytes, which may lead to T-lymphocyte activation and cell killing of tumor cells expressing KLK2 (NCI Drug Dictionary).

DrugClasses CD3 Antibody 93
CAS Registry Number NA
NCIT ID C180825


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cetrelimab + JNJ-78278343 Cetrelimab JNJ-78278343 0 1
JNJ-78278343 JNJ-78278343 0 1
JNJ-78278343 + JNJ-87189401 JNJ-78278343 JNJ-87189401 0 1

Additional content available in CKB BOOST